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tj.2012.1Abstract Kawasaki Disease (KD) is an acute systemic vasculitis of unknown etiology. In many
developed countries, KD has replaced rheumatic heart disease as the leading cause of acquired heart
disease in children. Among the classical criteria for a diagnosis of KD are oral manifestations such
as strawberry tongue, erythematous cracked lip, and oropharyngeal mucositis. We report the case
of a 24-year-old Saudi female with a history of Kawasaki disease who presented to our oral med-
icine clinic with recurrent painless swelling of the upper lip. As lip swelling has not previously been
reported as an oral manifestation of KD, this case represents a novel presentation of recurrent
Kawasaki disease in an adult female.
ª 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Kawasaki Disease (KD) was named after the Japanese pedia-
trician Tomisaku Kawasaki, who in 1967 described 50 cases in
which a rash and fever in early childhood were accompanied
by edema, conjunctival infection, redness and cracking of the
lips, ‘‘strawberry tongue,’’ convalescent desquamation, and
occasionally lymphadenopathy (Kawasaki, 1967; Kawasaki
et al., 1974).a Poster in the American
) 66th Annual Meeting at
l 2012.
Saud University.
g by Elsevier
. Production and hosting by Elsev
0.001Also known as Mucocutaneous Lymph Node Syndrome,
KD is an idiopathic infantile multi-organ vasculitis of medium
and small-sized arteries. It typically affects children of Asian
ethnicity younger than 4 years of age, although it may also oc-
cur in adults, where it is often misdiagnosed due to its nonspe-
ciﬁc clinical presentation (Kanno et al., 2011; Se`ve et al., 2005).
KD occurs more often in boys than in girls (1.5:1 male:female
ratio) (Cox and Sallis, 2009; Pemberton et al., 1999), and is
considered to be the most common cause of acquired pediatric
cardiac disease in developed countries (Bhatnagar et al., 2003).
Kawasaki disease has three phases. Most signs and symp-
toms appear during the initial acute febrile phase, which lasts
from 1 to 2 weeks. This is followed by a subacute phase, char-
acterized by desquamation, arthralgia, and elevated platelet
counts. This phase lasts from the end of the fever until approx-
imately day 25. Finally, during the convalescent phase, the
clinical signs disappear and acute-phase reactants such as
erythrocyte sedimentation rate (ESR) return to normal. The
average duration of Kawasaki disease is 6–8 weeks.ier B.V. All rights reserved.
44 A. FadenA diagnosis of KD requires the presence of at least ﬁve of
the six classic clinical features (Table 1) (Bhatnagar et al.,
2003; Scardina, 2007). Patients who exhibit fewer than this
number are considered to have Incomplete Kawasaki Disease
(IKD) or Atypical Kawasaki Disease (AKD) (Bhatnagar
et al., 2003; Cox and Sallis, 2009; Wolff et al., 2007). Although
there are no diagnostic laboratory tests available to rule the
disease in or out, some test results can support the clinical
diagnosis. For example; ESR, C-reactive protein, and platelets
are usually elevated, while antinuclear antibodies (ANAs) and
rheumatoid factors (RFs) are typically negative ((Bhatnagar
et al., 2003; Cox and Sallis, 2009). These tests can also be used
to rule out infectious diseases with a similar presentation, such
as scarlet fever caused by streptococcal infection, staphylococ-
cal infection, erythema multiforme, and measles. Where the
diagnosis is uncertain, failure of the fever to respond to antibi-
otics and steroids should lead the clinician to consider KD
(Se`ve et al., 2005; Bhatnagar et al., 2003).
Echocardiography should be obtained at the time of exam-
ination for all patients with an unresponsive fever where KD
or IKD is suspected (Pemberton et al., 1999).
Management of KD is aimed primarily at reducing inﬂam-
mation in the myocardium and the coronary arterial walls dur-
ing the acute phase of the disease, with the goal of preventing
coronary thrombosis. Aspirin and intravenous immunoglobu-
lin (IVIG) are the cornerstones of therapy (Bhatnagar et al.,
2003; Wolff et al., 2007).
The Ofﬁce of Rare Diseases (ORD) of the National Insti-
tutes of Health (NIH) lists Kawasaki disease as a rare disease,
with fewer than 200,000 people in the US affected by KD or
one of its subtypes ‘‘NIH Ofﬁce of Rare Diseases Research
(ORDR)’’. The prevalence of Kawasaki disease in the Middle
East region is not well documented, although isolated cases
have been reported from countries in the Arabian Gulf
(Bhatnagar et al., 2003; Ghazal et al., 1998; Al-Harbi, 2010;
Muzaffer and Al-Mayouf, 2002; Al-Mosawi et al., 2006;
Owa et al., 1995).
The recurrence rate of KD has been reported to be 0.8% in
the United States and 3% in Japan (Parmar et al., 2003;
Pemberton et al., 1999).
Dentists should be familiar with the oral and facial manifes-
tations of KD, as they might be involved in the diagnosis and
management of these patients (Bhatnagar et al., 2003;
Scardina, 2007). In particular, they should be alert to the fea-
tures of the acute disease, especially in patients with a historyTable 1 CDC diagnostic criteria for Kawasaki disease.
Fever lasting for 5 or more days without another, more reasonable, expl
1 Bilateral nonexudative conjunctival in
2 At least one of the following oral mu
– Red or dry ﬁssured lip
– Pharyngeal erythema
– Strawberry tongue
3 At least one of the following extremit
– Erythema of the palms and soles
– Edema of the hands and feet
– Generalized or periungual desqua
4 Polymorphous rash
5 Cervical lymphadenopathy, usually un
CDC – Center for Disease Control and Prevention9.of KD, and be aware of the possibility of recurrence and
cardiac valvular defects requiring antibiotic prophylaxis prior
to relevant dental treatment (Bhatnagar et al., 2003).
2. Case report
A 24-year-old Saudi female presented to the oral medicine
clinic at the College of Dentistry, King Saud University in Sau-
di Arabia with a chief complaint of recurrent unilateral swell-
ing of primarily the upper lip which usually resolved
spontaneously.
Informed consent was taken from the patient for publishing
her photographs. The ethical approval to carry out the inves-
tigations was obtained from the College of Dentistry Research
Center, King Saud University with project registration no. NF
2345.
She reported that the swelling was accompanied by a mild
skin rash as well as mild pain in the extremities, particularly
the hands and ﬁngers. She recently began to notice severe
bruising, which did not seem to be the result of trauma and
which persisted up to 3 weeks. She had also developed a num-
ber of new food allergies. She has been particularly concerned
with the recent onset of unilateral lip swellings, which typically
begin with itching, followed by swelling that lasted up to sev-
eral hours before subsiding spontaneously. One month after
the ﬁrst episode of lip swelling (Fig. 1), she became aware of
accompanying swelling of the ipsilateral eyelid (Fig. 2) and
cheek. She began to develop skin rashes which appeared to
alternate with the episodes of lip swelling. Usually occurring
on the extremities, the rashes began as areas of itching fol-
lowed by mild swelling with no formation of vesicle or crusts.
She additionally developed an allergy to a wide variety of den-
tal materials used in the dental school she was attending. Most
of these symptoms developed while regularly taking
antihistamines.
The patient had a history of Kawasaki disease. She was ﬁrst
admitted to the hospital at the age of 4, after having had a fe-
ver for more than 2 days, which had initially been diagnosed as
an upper respiratory tract infection. The fever persisted and
5 days later she was readmitted for further investigation. On
physical examination she was found to have congested eyes,
a red tongue, and a congested throat. ESR was elevated at
109 mm/h. The patient’s symptoms did not respond to treat-
ment with an antibiotic. Three days later, she developed right
upper quadrant abdominal swelling and was found to haveanation and at least four of the following criteria
fection
cous membranes changes:
ies changes
mation
ilateral (at least one lymph node > 1 cm in diameter)
Figure 1 Unilateral lip swelling.
Figure 2 Edema of the eye lid.
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results were normal and the patient appeared at the time to
have no cardiovascular complications. She remained unre-
sponsive to antibiotics and subsequently developed a truncal
maculopapular rash and was found to have mild left cervical
lymphadenopathy. One day after she commenced a high dose
of aspirin (100 mg/kg/d orally in 4 doses) the patient became
afebrile. However, after 2 days of aspirin therapy she devel-
oped vomiting, epigastric pain, and occult blood in the stool.
Aspirin was stopped and then restarted at a lower dose
(80 mg/kg p.o. daily) with Maalox suspension. Her ESR subse-
quently dropped to 72 mm/h.
Five days later her mycoplasma titer was 1:640 and her Sal-
monella typhi titer was 1:640, suggesting an immunoregulatory
abnormality that was likely secondary to vasculitis. Due to the
unavailability of IVIG in the hospital at that time, the patient
was discharged and then readmitted 5 days later when she was
given IVIG at a dose of 400 mg/kg/d over 4 successive days.
After treatment, the patient was found to be afebrile with an
ESR of 69 mm/h. She was then discharged on a low dose of
aspirin (50 mg p.o daily). One month later the patient was
readmitted complaining of fever, cough, and chest pain. Her
platelet count was 1,026,000 mm3 and ESR was elevated at
100 mm/h. Two-dimensional echocardiography revealed a
mild degree of long segment ectasia of both the left and rightcoronary arteries. The patient was clinically diagnosed with
Kawasaki disease complicated by non-giant coronary aneu-
rysms and was started on a brief regimen of a high-dose aspirin
therapy (100 mg/kg/day) then followed by a low dose (4 mg/
kg/day) and IVIG in a dose of 400 mg/kg/day by infusion in
4 successive days. The treatment plan included follow-up by
ECG and 2-D echocardiography to monitor cardiac involve-
ment. The patient was also to be continued on a low dose of
aspirin (2–5 mg/kg once daily) as well as dipyridamole (3–
5 mg/kg/d in 3 divided doses) to inhibit platelet aggregation
as long as the coronary aneurysms persisted.
Four years ago the patient complained of multiple episodes
of nausea, numbness in the extremities and sweating. A diag-
nosis of vasovagal syncope was made and the physicians ad-
vised the patient to avoid any stress or physical exertion. She
was referred to a cardiologist who performed echocardiogra-
phy which showed mild mitral regurgitation with a good ejec-
tion fraction of 65% and no wall motion abnormality. A 24-h
ECG Holter Monitor investigation was normal except for two
short runs of sinus tachycardia while walking with a heart rate
of 170 associated with central chest pressure-like pain. The
most likely diagnosis was positional vertigo. However, there
was a need to rule out any sequelae of KD associated with car-
diac arrhythmias which could be responsible for her com-
plaint. The cardiologist recommended a cardiac CT scan
which was highly suggestive of KD with involvement of the
proximal segment of the coronary arteries mainly the left main,
left anterior descending and the right coronary arteries. The af-
fected arteries demonstrated multiple areas of thickening and
aneurysmal formation with mild to moderate stenosis and a
small aneurysmal formation ranging from 3 to 5 mm in diam-
eter. The patient was strongly advised to continue aspirin ther-
apy as well as regular follow-up visits for observation. She was
informed that if the coronary arterial diameters were to grow
to more than 70% increase over normal values, she would re-
quire a coronary bypass operation.
The patient continued to take Aspirin (80 mg/day),
although she has expressed some resistance toward continuing
this therapy as per the advice of her physicians.
She was advised to see an immunologist for skin patch test-
ing. In 2010 she was diagnosed as having mild mitral regurgi-
tation and as a result has also been advised to see a
cardiologist for follow-up of this condition.
3. Discussion
Kawasaki disease is predominantly a disease of childhood,
although cases have been reported in adults (Gomard-Mennesson
et al., 2010; Wolff et al., 2007). It occurs primarily in the
Asian population. The mean annual incidence is 90–112 per
100,000 people. In the United States the mean annual inci-
dence is 6–9 per 100,000 children under 5 years of age, with
a peak incidence in children between 1 and 2 years of age
(Gedalia, 2002; Rozo et al., 2004). The mean annual incidence
in Britain and Australia is 3.6 and 3.7 per 100,000 people,
respectively.
In the Arab Gulf countries(Oman, Bahrain and Saudi Ara-
bia), cases of KD are infrequently reported, although the dis-
ease may be under diagnosed because of resemblance of the
clinical signs and symptoms with other diseases (Al-Harbi,
2010; Al-Mosawi et al., 2006; Bhatnagar et al., 2003; Muzaffer
46 A. Fadenand Al-Mayouf, 2002; Owa et al., 1995). In one retrospective
study conducted in the Madinah region of Saudi Arabia, inves-
tigators reviewed all pediatric cases over a 3-year period in
which a diagnosis of KD was suspected and in which the pa-
tient underwent cardiac evaluation. Of 51 cases, only 24 pa-
tients were conﬁrmed to have Kawasaki disease. Of the
conﬁrmed cases, most were of patients younger than 5 years
of age, with a male to female ratio of 1.7:1 (Al-Harbi,
2010;Bhatnagar et al., 2003; Ghazal et al., 1998; Muzaffer
and Al-Mayouf, 2002).
The likelihood of recurrence of Kawasaki disease increases
with age. Recurrence within 2 years of the initial onset of the
disease is unusual. Multiple recurrences have been reported
in rare cases having recurrences in adulthood (Parmar et al.,
2003; Pemberton et al., 1999). A high index of suspicion is
appropriate in patients with a conﬁrmed history of Kawasaki
disease who present with clinical signs consistent with the dis-
ease (Parmar et al., 2003; Pemberton et al., 1999).
Untreated disease usually resolves spontaneously after sev-
eral weeks (Pemberton et al., 1999; Rozo et al., 2004) even
though the major pathologic feature of KD is acute systemic
vasculitis. Coronary artery lesions usually develop early in
the acute phase, although they can infrequently develop more
than 4 weeks after the onset of the disease. These early lesions
are characterized by endothelial cell edema, proliferation,
necrosis, and adhesion of polymorphonuclear leukocytes to
the endothelium (Cox and Sallis, 2009; Thabet et al., 2011). Be-
cause one of the classical criteria for Kawasaki disease is oral
involvement, including lip erythema, dry cracked lips, and
involvement of the oropharyngeal mucosa (Bhatnagar et al.,
2003; Kanno et al., 2011),these signs may also be present in
the setting of recurrent KD (Parmar et al., 2003).
At the time of her last admission, the patient we report here
presented with ﬁve of the six principal criteria for Kawasaki
disease. These included: (1) a remittent fever that was unre-
sponsive to antibiotics; (2) bilateral conjunctival injection; (3)
a polymorphous truncal rash without vesicles or crusts; (4)
unilateral cervical lymphadenopathy; and (5) thrombocytosis.
She also exhibited oral manifestations including erythema of
the lips and oropharyngeal mucosa as well as a strawberry
tongue.
The patient’s chief complaint when she was presented to the
oral medicine clinic was lip swelling involving the cheek and
eye lids on the ipsilateral side. She was on an antihistamine
to exclude any allergic reaction to cats and foods, however,
she did not respond to the medication. Also, histories of phys-
ical or surgical traumas causing any lip swellings were excluded
as stated by the patient. No sign of any insect bite was ob-
served since the swelling repeated almost on the same site with
no response to antihistamine drugs. No relevance with any
medical syndromes was observed which might indicate the
involvement of any of the signs and symptoms e.g. Crohns’
Disease or Melkersson–Rosenthal Disease. Any other possible
cause for lip swellings was investigated with no direct causative
relevance emerged. All symptoms subsided spontaneously. She
also experienced a single episode of laryngoedema which also
resolved without treatment. Symptoms that the patient had
experienced were not related to any environmental changes.
The most recent laboratory results showed an ESR rate of
22 mm/h. Some of the clinical signs and symptoms includ-
ing lip involvement and the spontaneous resolution of theallergic-like reaction may suggest the possibility of a recur-
rence of KD in this case.
Early diagnosis of KD is essential, because administration
of IVIG within the ﬁrst 10 days of illness has been shown to
reduce the incidence of coronary artery aneurysms by a factor
of ﬁve (Bhatnagar et al., 2003; Cox and Sallis, 2009). Cardiac
complications occur in 20–25% of untreated patients, but in
only 4% of treated patients (Bhatnagar et al., 2003; Cox and
Sallis, 2009). The most common cardiac complication is
coronary artery aneurysm, although other sequelae have been
reported, including decreased myocardial contractility, conges-
tive heart failure, arrhythmias, pancarditis, pericardial
effusion, and myocardial ischemia (Cox and Sallis, 2009). Cor-
onary artery aneurysms usually become apparent 1–3 weeks
after the onset of fever, and resolve in 50% of patients within
5–18 months (Cox and Sallis, 2009; Rozo et al., 2004). Esti-
mates of the incidence of under diagnosed conditions attempt
to justify a larger incidence rate than is reported by doctors or
medical authorities; whereas other rates may use only the
ofﬁcial reported rates. In view of these potentially avoidable
outcomes and because KD is under diagnosed, it is important
to have a high degree of suspicion for the disease in any child
with prolonged unexplained fevers (Bhatnagar et al., 2003).
The standard of care for children with acute Kawasaki dis-
ease is a single, 2 mg/kg infusion of IVIG along with aspirin at
a dose of 80–100 mg/kg/day in 4 divided doses (Wolff et al.,
2007). Aspirin can be decreased to 3–5 mg/kg/d once the fever
has resolved doses (Burns et al., 2000; Ghazal et al., 1998;
Wolff et al., 2007). In patients with coronary artery aneurysms,
aspirin should be continued until 2 years after the aneurysms
resolve. If aneurysms do not resolve, then aspirin therapy
should be continued indeﬁnitely to prevent coronary artery
thrombosis (Wolff et al., 2007).
Although the patient reported here was admitted during the
initial episode of her disease and presented with all of the cri-
teria of the acute febrile phase, the delayed diagnosis led to the
delayed administration of IVIG. This may ultimately have
been responsible for the observed late recurrence of the oral
manifestations (Parmar et al., 2003; Pemberton et al., 1999).
Dentists and oral medicine specialists are not usually in-
volved in the diagnostic process of Kawasaki disease in chil-
dren since the persistent fever tends to be the parents’ main
concern. The oral manifestations of the disease are important
to recognize since they may be overlooked by the general phy-
sician. Dentists have the opportunity to play an important role
in assisting other health professionals in the early diagnosis of
this rare disease.References
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